These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16634706)

  • 41. Regimen-related gastrointestinal toxicities in cancer patients.
    Sonis ST
    Curr Opin Support Palliat Care; 2010 Mar; 4(1):26-30. PubMed ID: 20040879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation induced oral mucositis: a review of current literature on prevention and management.
    Mallick S; Benson R; Rath GK
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2285-93. PubMed ID: 26116012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging therapies for the prevention and treatment of oral mucositis.
    Yuan A; Sonis S
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):343-51. PubMed ID: 25102771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Updated clinical practice guidelines for the prevention and treatment of mucositis.
    Keefe DM; Schubert MM; Elting LS; Sonis ST; Epstein JB; Raber-Durlacher JE; Migliorati CA; McGuire DB; Hutchins RD; Peterson DE;
    Cancer; 2007 Mar; 109(5):820-31. PubMed ID: 17236223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis.
    Reyes-Gibby CC; Melkonian SC; Wang J; Yu RK; Shelburne SA; Lu C; Gunn GB; Chambers MS; Hanna EY; Yeung SJ; Shete S
    PLoS One; 2017; 12(7):e0180396. PubMed ID: 28678827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.
    Vigarios E; Epstein JB; Sibaud V
    Support Care Cancer; 2017 May; 25(5):1713-1739. PubMed ID: 28224235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of head and neck cancers: issues for clinical pharmacists.
    Scarpace SL; Brodzik FA; Mehdi S; Belgam R
    Pharmacotherapy; 2009 May; 29(5):578-92. PubMed ID: 19397465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy or radiation-induced oral mucositis.
    Lalla RV; Saunders DP; Peterson DE
    Dent Clin North Am; 2014 Apr; 58(2):341-9. PubMed ID: 24655526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis.
    Thomsen M; Vitetta L
    Integr Cancer Ther; 2018 Dec; 17(4):1027-1047. PubMed ID: 30136590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectives.
    Niscola P; Scaramucci L; Giovannini M; Ales M; Bondanini F; Cupelli L; Dentamaro T; Lamanda M; Natale G; Palumbo R; Romani C; Tendas A; Tolu B; Violo L; de Fabritiis P
    Cardiovasc Hematol Agents Med Chem; 2009 Oct; 7(4):305-12. PubMed ID: 19607642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in the Use of Anti-inflammatory Agents to Manage Chemotherapy-induced Oral and Gastrointestinal Mucositis.
    Mahendran VJ; Stringer AM; Semple SJ; Song Y; Garg S
    Curr Pharm Des; 2018; 24(14):1518-1532. PubMed ID: 29629657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Current approaches in prevention and therapy of chemo- and radiotherapy-induced oral mucositis].
    Rosenthal C; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):53-65. PubMed ID: 11789420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current trends in the management of oral mucositis related to cancer treatment.
    Biswal BM
    Malays J Med Sci; 2008 Jul; 15(3):4-13. PubMed ID: 22570584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review.
    Plevová P
    Oral Oncol; 1999 Sep; 35(5):453-70. PubMed ID: 10694945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis.
    von Bültzingslöwen I; Brennan MT; Spijkervet FK; Logan R; Stringer A; Raber-Durlacher JE; Keefe D
    Support Care Cancer; 2006 Jun; 14(6):519-27. PubMed ID: 16775647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Head and neck radiation and mucositis.
    Garden AS; Chambers MS
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):30-4. PubMed ID: 18660721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of gastrointestinal side-effects in paediatric oncology: what are the guidelines?
    Cheng KKF
    Curr Opin Support Palliat Care; 2017 Jun; 11(2):120-124. PubMed ID: 28333866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylene Blue for the Treatment of Intractable Pain Associated with Oral Mucositis.
    Roldan CJ; Nouri K; Chai T; Huh B
    Pain Pract; 2017 Nov; 17(8):1115-1121. PubMed ID: 28226414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy-induced oral mucositis. Prevention and management.
    Knox JJ; Puodziunas AL; Feld R
    Drugs Aging; 2000 Oct; 17(4):257-67. PubMed ID: 11087004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.